Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 342.69M | $ -171.52M | -50.05% |
3/31/2025 | $ 371.74M | $ -175.88M | -47.31% |
12/31/2024 | $ 403.99M | $ -186.26M | -46.11% |
9/30/2024 | $ 461.3M | $ -178.23M | -38.64% |
6/30/2024 | $ 497.54M | $ -175.72M | -35.32% |
3/31/2024 | $ 528.18M | $ -190.05M | -35.98% |
12/31/2023 | $ 471.95M | $ -160.93M | -34.1% |
9/30/2023 | $ 507.73M | $ -173.17M | -34.11% |
6/30/2023 | $ 544.1M | $ -211.56M | -38.88% |
3/31/2023 | $ 585.09M | $ -234.91M | -40.15% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for FATE THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -148.58M ] / Inv. Capital [ $ 509.85M ]
(=) ROIC [ -29.14% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.67% |
median | 3.38% |
std | 15.18% |